Dimensional Fund Advisors’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.3M | Buy |
1,894,992
+179,605
| +10% | +$6.47M | 0.02% | 1306 |
|
|
2025
Q1 | $53.4M | Buy |
1,715,387
+34,852
| +2% | +$1.09M | 0.01% | 1435 |
|
|
2024
Q4 | $42.9M | Buy |
1,680,535
+580,787
| +53% | +$14.8M | 0.01% | 1601 |
|
|
2024
Q3 | $31.1M | Buy |
1,099,748
+312,491
| +40% | +$8.84M | 0.01% | 1778 |
|
|
2024
Q2 | $20.8M | Buy |
787,257
+139,761
| +22% | +$3.69M | 0.01% | 1936 |
|
|
2024
Q1 | $19.7M | Buy |
647,496
+18,927
| +3% | +$575K | 0.01% | 1995 |
|
|
2023
Q4 | $17.7M | Buy |
628,569
+126,705
| +25% | +$3.56M | 0.01% | 2048 |
|
|
2023
Q3 | $13.6M | Buy |
501,864
+99,317
| +25% | +$2.69M | ﹤0.01% | 2102 |
|
|
2023
Q2 | $12.4M | Buy |
402,547
+12,588
| +3% | +$387K | ﹤0.01% | 2163 |
|
|
2023
Q1 | $14.1M | Buy |
389,959
+64,882
| +20% | +$2.34M | ﹤0.01% | 2075 |
|
|
2022
Q4 | $12.8K | Sell |
325,077
-10,362
| -3% | -$410 | ﹤0.01% | 2085 |
|
|
2022
Q3 | $13.5M | Buy |
335,439
+42,479
| +14% | +$1.71M | 0.01% | 2033 |
|
|
2022
Q2 | $12.3M | Buy |
292,960
+8,019
| +3% | +$337K | ﹤0.01% | 2108 |
|
|
2022
Q1 | $11.1M | Buy |
284,941
+54,740
| +24% | +$2.13M | ﹤0.01% | 2246 |
|
|
2021
Q4 | $9.17M | Buy |
230,201
+69,686
| +43% | +$2.78M | ﹤0.01% | 2340 |
|
|
2021
Q3 | $5.8M | Buy |
160,515
+151,369
| +1,655% | +$5.47M | ﹤0.01% | 2544 |
|
|
2021
Q2 | $375K | Sell |
9,146
-295
| -3% | -$12.1K | ﹤0.01% | 3217 |
|
|
2021
Q1 | $413K | Buy |
+9,441
| New | +$413K | ﹤0.01% | 3176 |
|